Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (35)
Guidance programme
(
1 selected
)
Guidance programme
Cancer service guidelines (1)
Clinical guidelines (3)
Diagnostics guidance (2)
Interventional procedures guidance (5)
Medical technologies guidance (1)
NICE guidelines (4)
Technology appraisal guidance (35)
Apply filters
Showing 21 to 30 of 35
Sort by
Date
Title
Apply sorting
breast cancer
Remove breast cancer filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive
breast cancer
TA509
7 March 2018
7 March 2018
Intrabeam radiotherapy system for adjuvant treatment of early
breast cancer
TA501
31 January 2018
31 January 2018
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive
breast cancer
TA503
31 January 2018
31 January 2018
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic
breast cancer
TA495
20 December 2017
20 December 2017
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic
breast cancer
TA496
20 December 2017
20 December 2017
Trastuzumab emtansine for treating HER2-positive advanced
breast cancer
after trastuzumab and a taxane
TA458
19 July 2017
20 November 2017
Everolimus with exemestane for treating advanced
breast cancer
after endocrine therapy
TA421
21 December 2016
21 December 2016
Eribulin for treating locally advanced or metastatic
breast cancer
after 2 or more chemotherapy regimens
TA423
21 December 2016
21 December 2016
Pertuzumab for the neoadjuvant treatment of HER2-positive
breast cancer
TA424
21 December 2016
21 December 2016
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic
breast cancer
TA263
22 August 2012
22 August 2012
Previous page
1
2
Current page
3
4
Page
3
of
4
Next page
Results per page
10
25
50
All
Back to top